Skip to main content

Epigenetics and DOHaD: from basics to birth and beyond

  • T. Bianco-Miotto (a1), J. M. Craig (a2), Y. P. Gasser (a2), S. J. van Dijk (a3) and S. E. Ozanne (a4)...

Developmental origins of health and disease (DOHaD) is the study of how the early life environment can impact the risk of chronic diseases from childhood to adulthood and the mechanisms involved. Epigenetic modifications such as DNA methylation, histone modifications and non-coding RNAs are involved in mediating how early life environment impacts later health. This review is a summary of the Epigenetics and DOHaD workshop held at the 2016 DOHaD Society of Australia and New Zealand Conference. Our extensive knowledge of how the early life environment impacts later risk for chronic disease would not have been possible without animal models. In this review we highlight some animal model examples that demonstrate how an adverse early life exposure results in epigenetic and gene expression changes that may contribute to increased risk of chronic disease later in life. Type 2 diabetes and cardiovascular disease are chronic diseases with an increasing incidence due to the increased number of children and adults that are obese. Epigenetic changes such as DNA methylation have been shown to be associated with metabolic health measures and potentially predict future metabolic health status. Although more difficult to elucidate in humans, recent studies suggest that DNA methylation may be one of the epigenetic mechanisms that mediates the effects of early life exposures on later life risk of obesity and obesity related diseases. Finally, we discuss the role of the microbiome and how it is a new player in developmental programming and mediating early life exposures on later risk of chronic disease.

Corresponding author
*Address for correspondence: T. Bianco-Miotto, School of Agriculture, Food and Wine, Waite Research Institute & Robinson Research Institute, University of Adelaide, SA, 5005, Australia. (Email
Hide All
1. Jablonka, E, Lamb, MJ. The changing concept of epigenetics. Ann N Y Acad Sci. 2002; 981, 8296.
2. Blewitt, M, Whitelaw, E. The use of mouse models to study epigenetics. Cold Spring Harb Perspect Biol. 2013; 5, a017939.
3. Rosenfeld, CS. Animal models to study environmental epigenetics. Biol Reprod. 2010; 82, 473488.
4. Poulsen, P, Esteller, M, Vaag, A, Fraga, MF. The epigenetic basis of twin discordance in age-related diseases. Pediatr Res. 2007; 61(5 Pt 2), 38R42R.
5. Castillo-Fernandez, JE, Spector, TD, Bell, JT. Epigenetics of discordant monozygotic twins: implications for disease. Genome Med. 2014; 6, 60.
6. Marx, V. Epigenetics: reading the second genomic code. Nature. 2012; 491, 143147.
7. Jang, HS, Shin, WJ, Lee, JE, Do, JT. CpG and non-CpG methylation in epigenetic gene regulation and brain function. Genes (Basel). 2017; 8, 148.
8. Zhong, X. Comparative epigenomics: a powerful tool to understand the evolution of DNA methylation. New Phytol. 2016; 210, 7680.
9. Tessarz, P, Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014; 15, 703708.
10. Zhang, T, Cooper, S, Brockdorff, N. The interplay of histone modifications – writers that read. EMBO Rep. 2015; 16, 14671481.
11. Du, J, Johnson, LM, Jacobsen, SE, Patel, DJ. DNA methylation pathways and their crosstalk with histone methylation. Nat Rev Mol Cell Biol. 2015; 16, 519532.
12. Cora, D, Re, A, Caselle, M, Bussolino, F. MicroRNA-mediated regulatory circuits: outlook and perspectives. Phys Biol. 2017; 14, 045001.
13. Karlsson, O, Baccarelli, AA. Environmental health and long non-coding RNAs. Curr Environ Health Rep. 2016; 3, 178187.
14. Barker, DJ. The fetal and infant origins of adult disease. BMJ. 1990; 301, 1111.
15. Gluckman, PD, Hanson, MA, Cooper, C, Thornburg, KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359, 6173.
16. Barouki, R, Gluckman, PD, Grandjean, P, Hanson, M, Heindel, JJ. Developmental origins of non-communicable disease: implications for research and public health. Environ Health. 2012; 11, 42.
17. Lillycrop, KA, Phillips, ES, Jackson, AA, Hanson, MA, Burdge, GC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005; 135, 13821386.
18. Weaver, IC, Cervoni, N, Champagne, FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004; 7, 847854.
19. Park, JH, Stoffers, DA, Nicholls, RD, Simmons, RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest. 2008; 118, 23162324.
20. Sandovici, I, Smith, NH, Nitert, MD, et al. Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci USA. 2011; 108, 54495454.
21. Ferland-McCollough, D, Fernandez-Twinn, DS, Cannell, IG, et al. Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes. Cell Death Differ. 2012; 19, 10031012.
22. Maloyan, A, Muralimanoharan, S, Huffman, S, et al. Identification and comparative analyses of myocardial miRNAs involved in the fetal response to maternal obesity. Physiol Genomics. 2013; 45, 889900.
23. Chambers, JC, Loh, M, Lehne, B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015; 3, 526534.
24. Dayeh, T, Tuomi, T, Almgren, P, et al. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics. 2016; 11, 482488.
25. Demerath, EW, Guan, W, Grove, ML, et al. Epigenome-wide association study (EWAS) of BMI, BMI change and waist circumference in African American adults identifies multiple replicated loci. Hum Mol Genet. 2015; 24, 44644479.
26. Dick, KJ, Nelson, CP, Tsaprouni, L, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014; 383, 19901998.
27. Pan, H, Lin, X, Wu, Y, et al. HIF3A association with adiposity: the story begins before birth. Epigenomics. 2015; 7, 937950.
28. Soriano-Tarraga, C, Jimenez-Conde, J, Giralt-Steinhauer, E, et al. Epigenome-wide association study identifies TXNIP gene associated with type 2 diabetes mellitus and sustained hyperglycemia. Hum Mol Genet. 2016; 25, 609619.
29. Wang, B, Gao, W, Li, J, et al. Methylation loci associated with body mass index, waist circumference, and waist-to-hip ratio in Chinese adults: an epigenome-wide analysis. Lancet. 2016; 388(Suppl. 1), S21.
30. Wang, S, Song, J, Yang, Y, et al. HIF3A DNA methylation is associated with childhood obesity and ALT. PLoS One. 2015; 10, e0145944.
31. Wahl, S, Drong, A, Lehne, B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017; 541, 8186.
32. Relton, CL, Davey Smith, G. Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease. Int J Epidemiol. 2012; 41, 161176.
33. Barres, R, Kirchner, H, Rasmussen, M, et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 2013; 3, 10201027.
34. Benton, MC, Johnstone, A, Eccles, D, et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol. 2015; 16, 8.
35. Multhaup, ML, Seldin, MM, Jaffe, AE, et al. Mouse-human experimental epigenetic analysis unmasks dietary targets and genetic liability for diabetic phenotypes. Cell Metab. 2015; 21, 138149.
36. Clarke-Harris, R, Wilkin, TJ, Hosking, J, et al. PGC1alpha promoter methylation in blood at 5-7 years predicts adiposity from 9 to 14 years (EarlyBird 50). Diabetes. 2014; 63, 25282537.
37. Godfrey, KM, Sheppard, A, Gluckman, PD, et al. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes. 2011; 60, 15281534.
38. Sharp, GC, Lawlor, DA, Richmond, RC, et al. Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2015; 44, 12881304.
39. Tobi, EW, Goeman, JJ, Monajemi, R, et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun. 2014; 5, 5592.
40. Dominguez-Salas, P, Moore, SE, Baker, MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014; 5, 3746.
41. Rando, OJ, Simmons, RA. I’m eating for two: parental dietary effects on offspring metabolism. Cell. 2015; 161, 93105.
42. Godfrey, KM, Reynolds, RM, Prescott, SL, et al. Influence of maternal obesity on the long-term health of offspring. Lancet Diabetes Endocrinol. 2017; 5, 5364.
43. Donkin, I, Versteyhe, S, Ingerslev, LR, et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 2016; 23, 369378.
44. Kuhnen, P, Handke, D, Waterland, RA, et al. Interindividual variation in DNA methylation at a putative POMC metastable epiallele is associated with obesity. Cell Metab. 2016; 24, 502509.
45. Perco, P, Wilflingseder, J, Bernthaler, A, et al. Biomarker candidates for cardiovascular disease and bone metabolism disorders in chronic kidney disease: a systems biology perspective. J Cell Mol Med. 2008; 12, 11771187.
46. Shu, L, Zhao, Y, Kurt, Z, et al. Mergeomics: multidimensional data integration to identify pathogenic perturbations to biological systems. BMC Genomics. 2016; 17, 874.
47. Levy, M, Thaiss, CA, Elinav, E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. 2016; 30, 15891597.
48. Mischke, M, Plosch, T. The gut microbiota and their metabolites: potential implications for the host epigenome. Adv Exp Med Biol. 2016; 902, 3344.
49. Thorburn, AN, Macia, L, Mackay, CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity. 2014; 40, 833842.
50. Berding, K, Donovan, SM. Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs. Nutr Rev. 2016; 74, 723736.
51. Shapiro, H, Thaiss, CA, Levy, M, Elinav, E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol. 2014; 30, 5462.
52. Cortese, R, Lu, L, Yu, Y, Ruden, D, Claud, EC. Epigenome-microbiome crosstalk: a potential new paradigm influencing neonatal susceptibility to disease. Epigenetics. 2016; 11, 205215.
53. Yu, DH, Gadkari, M, Zhou, Q, et al. Postnatal epigenetic regulation of intestinal stem cells requires DNA methylation and is guided by the microbiome. Genome Biol. 2015; 16, 211.
54. Kumar, H, Lund, R, Laiho, A, et al. Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. mBio. 2014; 5, e0211314.
55. Bierne, H, Hamon, M, Cossart, P. Epigenetics and bacterial infections. Cold Spring Harb Perspect Med. 2012; 2, a010272.
56. Paschos, K, Allday, MJ. Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol. 2010; 18, 439447.
57. Bonder, MJ, Kurilshikov, A, Tigchelaar, EF, et al. The effect of host genetics on the gut microbiome. Nat Genet. 2016; 48, 14071412.
58. Turpin, W, Espin-Garcia, O, Xu, W, et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet. 2016; 48, 14131417.
59. Beaumont, M, Goodrich, JK, Jackson, MA, et al. Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol. 2016; 17, 189.
60. Goodrich, JK, Waters, JL, Poole, AC, et al. Human genetics shape the gut microbiome. Cell. 2014; 159, 789799.
61. Takahashi, K, Sugi, Y, Hosono, A, Kaminogawa, S. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J Immunol. 2009; 183, 65226529.
62. Takahashi, K, Sugi, Y, Nakano, K, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem. 2011; 286, 3575535762.
63. Liu, S, da Cunha, AP, Rezende, RM, et al. The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe. 2016; 19, 3243.
64. Schroeder, BO, Backhed, F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016; 22, 10791089.
65. Remely, M, Haslberger, AG. The microbial epigenome in metabolic syndrome. Mol Aspects Med. 2016; 54, 7177.
66. Krautkramer, KA, Kreznar, JH, Romano, KA, et al. Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol Cell. 2016; 64, 982992.
67. Worthley, DL, Whitehall, VL, Le Leu, RK, et al. DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. Dig Dis Sci. 2011; 56, 387396.
68. Remely, M, Aumueller, E, Merold, C, et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene. 2014; 537, 8592.
69. Lukovac, S, Belzer, C, Pellis, L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio. 2014; 5, e0143814.
70. Lynch, SV, Pedersen, O. The human intestinal microbiome in health and disease. N Engl J Med. 2016; 375, 23692379.
71. Zmora, N, Zeevi, D, Korem, T, Segal, E, Elinav, E. Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe. 2016; 19, 1220.
72. Ahmad, I, Nasiruddin, M, Khan, MA, et al. Nutraceuticals as chemopreventive and therapeutic agents in gut associated pathogenesis. Biochem Anal Biochem. 2016; 5, 298.
73. Remely, M, Ferk, F, Sterneder, S, et al. EGCG prevents high fat diet-induced changes in gut microbiota, decreases of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57BL/6J male mice. Oxid Med Cell Longev. Epub 2017 Jan 4.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of Developmental Origins of Health and Disease
  • ISSN: 2040-1744
  • EISSN: 2040-1752
  • URL: /core/journals/journal-of-developmental-origins-of-health-and-disease
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 71
Total number of PDF views: 376 *
Loading metrics...

Abstract views

Total abstract views: 1471 *
Loading metrics...

* Views captured on Cambridge Core between 11th September 2017 - 16th August 2018. This data will be updated every 24 hours.